Biochemists and biophysicists

What AI will never replace

AI can predict a protein's structure, but designing the actual experiment to test whether that structure matters in a living cell — choosing the right model organism, troubleshooting a Western blot that keeps failing, or recognizing that an unexpected result is more interesting than the original hypothesis — remains a human act. Securing multi-year NIH funding requires building a narrative that connects preliminary data to a compelling scientific question, which involves persuading review panels in person. Physical lab troubleshooting, like figuring out why a cell culture keeps dying despite identical protocols, demands hands-on detective work no simulation replaces.

AI exposure: 7/10

This occupation is heavily centered on knowledge work, data analysis, and complex modeling, all of which are being revolutionized by AI (e.g., AlphaFold for protein structure prediction). While physical laboratory work and team management provide a buffer, a significant portion of the role involves literature review, grant writing, and data interpretation—tasks where AI can exponentially increase productivity or automate core analytical functions.

AI advantage: 8/10

AI tools like AlphaFold and generative models for drug discovery have fundamentally transformed core tasks such as protein folding prediction and molecular synthesis. Adopters can process massive datasets and simulate biological processes exponentially faster than traditional methods, while also automating the heavy administrative burden of grant writing and literature reviews.

Job growth outlook: 9/10

AI is revolutionizing biochemistry through breakthroughs like AlphaFold, which drastically reduces the time and cost of protein folding and drug discovery, unlocking massive latent demand for new therapeutics. While AI automates data analysis, it creates a surge in demand for PhD-level scientists to design AI-driven experiments, validate computational predictions in wet labs, and navigate the complex regulatory and ethical landscapes of synthetic biology. The field is shifting from traditional trial-and-error to an 'AI-first' discovery model, which requires more specialized biochemists to manage the resulting explosion in research pipelines.

Career details

• Typical education: Doctoral or professional degree
• Median annual pay: $103,650
• 10-year outlook: Faster than average